Embolx, Inc.
- Nov 1, 2022 · D · $1,629,000 sold of $1,629,000 · 5 investors · min. No minimum reported · role: Executive Officer (Director of Finance) EDGAR ↗
Raised $1.63M from 5 investors (100% of the $1.63M target) as of the latest filing. Michael is listed as executive officer.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.